Frank Karbe - Apr 25, 2022 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role
Director
Signature
/s/ Larry Miller, Attorney-in-Fact for Frank Karbe
Stock symbol
PHAT
Transactions as of
Apr 25, 2022
Transactions value $
$0
Form type
4
Date filed
4/26/2022, 05:21 PM
Previous filing
Jul 9, 2021
Next filing
May 27, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHAT Stock Option (Right to Buy) Award $0 +20 K $0.00 20 K Apr 25, 2022 Common Stock 20 K $13.61 Direct F1

Explanation of Responses:

Id Content
F1 The stock option will vest with respect to one-third of the shares of common stock on April 25, 2023, and will vest in substantially equal quarterly installments over the twenty-four (24) months thereafter, subject to the reporting person's continuous service to the Issuer on the applicable vesting dates.